Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR9 | P51686 | 18/20 | 0.76 |
| ▸ | BDKRB1 | P46663 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL344413 | 0.86 | CCR9 (1.00) | CCR9BDKRB1 | |
| SCHEMBL344098 | 0.86 | CCR9 (1.00) | CCR9LMNAHTT | |
| SCHEMBL12482084 | 0.83 | CCR9 (0.78) | CCR9BDKRB1 | |
| SCHEMBL13950808 | 0.79 | LMNA (0.74) | CCR9BDKRB1LMNAHTT | |
| SCHEMBL344936 | 0.78 | CCR9 (0.86) | CCR9LMNAHTT | |
| SCHEMBL2169219 | 0.77 | CCR9 (1.00) | CCR9LMNAHTT | |
| SCHEMBL2168505 | 0.76 | CCR9 (1.00) | CCR9LMNAHTT | |
| SCHEMBL344361 | 0.76 | CCR9 (0.81) | CCR9BDKRB1 | |
| SCHEMBL14311492 | 0.76 | CCR9 (0.61) | CCR9BDKRB1LMNAHTT | |
| SCHEMBL343310 | 0.75 | CCR9 (0.70) | CCR9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090163498-A1 | Aryl Sulfonamides | CHEMOCENTRYX, INC. (US) | 2009-06-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090163498-A1 | Aryl Sulfonamides | CCR9, CCR1, CCR2 | CCR9 1/4885BDKRB1 429/4885LMNA 4484/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.